Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

Comment by MartialArtson Feb 18, 2018 6:32pm
107 Views
Post# 27581414

RE:RE:RE:No bidding wars for CMED nonesense

RE:RE:RE:No bidding wars for CMED nonesense


Thank you for the compliments.  There are times when I wonder why I spend any time here but the positive and constructive comments I get here and via private messenging makes it worthwhile.

I truly think this community would get more if we all collaborated in a positive manner and I'm happy to continue to do so.

This is starting to get easier to see.  As easy as when the stock was trading below $20 and shot up to $45.  Except this round it will be from $33 to $66.  I get the feeling the holders of the 33.3% that ACB needs are from the more savvy crowd that understand how Aurora operates.

I have enough experience to see that the action on Friday was pure manipulation by pros to get cheap shares.  I normally have stops but I'm seeing pros go shopping for stops and triggering them so this requires constant attention.  So instead of stops, I'm ready to ride it down and just add.  I have a lot more funds I can throw in.

So instead of stops, I just buy on the short term charts which showed how oversold CMED was during portions of Friday.  Very interesting day trading and anything under $43 is easy to buy.

Pros pushed ACB down to single digits and, it's clear they were ready to pick up CMED at $33 or below.  Have a look at who picked up CMED in the high $32s. And I would not be surprised it gets pushed down even lower.

And you are abolutely right CMED at $800M is an absolute steal compared to NUU at a higher price.  And the "all shares" mergers is how these big players continue to get bigger.

Aurora was smart to "lock up" 50% of the shares but the 16% more they need to reach 66.6% will be the battle ground.  They can start buying on the market Tuesday so why would they not pick up as many shares as they can under $43?  That no only gives them cheaper than Offer price but ensures they have the votes to close this and get this over with.

Looking at all the discussions on the ACB bullboard, there's is much that is very "deep" unfortunately. Lots of misbehaved kids and bad actors.  There's a lot of noise but very little substance.  I'm surprised that long time holders such as DD didn't jump on CMED when he had the chance but decided to stay with ACB?    He's not explaining why he did that which really puzzles me. 

One thing for sure, ACB has all the reasons to bring CMED to its "implied" value price since it leaves a wide open door for shareholders like me to wish for a better partner at this point in time.

<< Previous
Bullboard Posts
Next >>